DXCM President & COO Leach buys 18.2K shares for $1.0M on 2025-11-10; stock down 39.6% from 52-week high
Leach Jacob Steven, President & COO of Dexcom, executed two separate purchases on 2025-11-10 totaling 18,200 shares for $1,001,701.90 at a blended average price of $55.04, increasing his holdings by 5.8%. The transaction occurred as the stock trades at $54.84, down 39.6% from its 52-week high of $90.75 and down 15.8% over the prior 30 days. Leach's prior trading record at DXCM shows mixed outcomes: his three prior sales (2025-03-12, 2024-03-12, 2023-04-20) produced a 90-day well-timed rate of 33.33%, with only 1 of 3 sales being well-timed at the 90-day horizon. The company reports strong fundamentals with revenue of $1,209,300,000.00, net income of $283,800,000.00, and 11.3% annual revenue growth, though trading at a P/E of 29.64. The magnitude of this buy—$1.0M—and its execution during a period of substantial stock decline merit monitoring for signals about management's assessment of valuation at these depressed price levels.